BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Apple
AAPL
|
+$487M |
| 2 |
Industrial Select Sector SPDR Fund
XLI
|
+$393M |
| 3 |
Microsoft
MSFT
|
+$380M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
+$349M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$312M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 2 |
Salesforce
CRM
|
+$765M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$368M |
| 4 |
Eli Lilly
LLY
|
+$255M |
| 5 |
AGN
Allergan plc
AGN
|
+$225M |
Sector Composition
| 1 | Technology | 18.31% |
| 2 | Consumer Discretionary | 8.56% |
| 3 | Healthcare | 8.43% |
| 4 | Financials | 7.4% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Upland Software
UPLD
$71.6M
| $29.1K | ﹤0.01% |
838
-6,246
| -88% | -$217K |
|
|
CNSL
2477
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $29K | ﹤0.01% |
4,278
-24,772
| -85% | -$168K |
|
2478
Enterprise Financial Services Corp
EFSC
$2.24B
| $28.9K | ﹤0.01% |
930
-6,655
| -88% | -$207K |
|
2479
Movado Group
MOV
$438M
| $28.9K | ﹤0.01% |
2,667
-5,094
| -66% | -$55.2K |
|
2480
Synlogic
SYBX
$18.6M
| $28.9K | ﹤0.01% |
949
+605
| +176% | +$18.4K |
|
2481
The RMR Group
RMR
$288M
| $28.8K | ﹤0.01% |
978
-4,105
| -81% | -$121K |
|
2482
Golar LNG
GLNG
$4.16B
| $28.7K | ﹤0.01% |
3,968
-25,868
| -87% | -$187K |
|
|
CCF
2483
DELISTED
Chase Corporation
CCF
| $28.7K | ﹤0.01% |
280
-1,987
| -88% | -$204K |
|
2484
Argan
AGX
$3.18B
| $28.7K | ﹤0.01% |
605
-3,948
| -87% | -$187K |
|
|
CLDT
2485
Chatham Lodging
CLDT
$348M
| $28.7K | ﹤0.01% |
4,683
-13,674
| -74% | -$83.7K |
|
2486
Kulicke & Soffa
KLIC
$2.01B
| $28.6K | ﹤0.01% |
1,372
-4,393
| -76% | -$91.5K |
|
|
LGF.A
2487
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $28.5K | ﹤0.01% |
3,852
-4,173
| -52% | -$30.9K |
|
2488
Extreme Networks
EXTR
$2.95B
| $28.4K | ﹤0.01% |
6,544
-40,361
| -86% | -$175K |
|
2489
Banc of California
BANC
$2.62B
| $28.2K | ﹤0.01% |
2,605
-15,580
| -86% | -$169K |
|
2490
Forrester Research
FORR
$195M
| $28K | ﹤0.01% |
875
-3,627
| -81% | -$116K |
|
|
OPTN
2491
DELISTED
OptiNose
OPTN
| $27.9K | ﹤0.01% |
250
-286
| -53% | -$32K |
|
2492
UroGen Pharma
URGN
$869M
| $27.9K | ﹤0.01% |
1,067
-5,031
| -83% | -$131K |
|
2493
Sapiens International
SPNS
$2.4B
| $27.3K | ﹤0.01% |
+974
| New | +$27.3K |
|
2494
First Bancorp
FBNC
$2.29B
| $26.9K | ﹤0.01% |
1,074
-8,085
| -88% | -$203K |
|
2495
Bally's
BALY
$487M
| $26.9K | ﹤0.01% |
1,207
-4,544
| -79% | -$101K |
|
|
MFGP
2496
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $26.8K | ﹤0.01% |
4,897
+2,260
| +86% | +$12.4K |
|
|
PENG
2497
Penguin Solutions, Inc. Ordinary Shares
PENG
$1.36B
| $26.7K | ﹤0.01% |
1,962
-10,952
| -85% | -$149K |
|
|
ORC
2498
Orchid Island Capital
ORC
$1.04B
| $26.6K | ﹤0.01% |
1,131
-3,174
| -74% | -$74.8K |
|
|
GOOD
2499
Gladstone Commercial Corp
GOOD
$608M
| $26.6K | ﹤0.01% |
1,420
-8,297
| -85% | -$156K |
|
2500
Crinetics Pharmaceuticals
CRNX
$3.2B
| $26.6K | ﹤0.01% |
1,516
-1,931
| -56% | -$33.8K |
|